$UBI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UNIVERSAL BIOSENSORS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in UNIVERSAL BIOSENSORS INC. Get notifications about new insider transactions in UNIVERSAL BIOSENSORS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 11 2021 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Sell | S | 0.00 | 12,559,109 | 0 | 27,246,227 | 39.8 M to 27.2 M (-31.55 %) |
Dec 23 2020 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 40,000 | 0 | 0 | |
Dec 23 2020 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | M | 0.00 | 40,000 | 0 | 266,558 | 226.6 K to 266.6 K (+17.66 %) |
Nov 03 2020 | UBI | UNIVERSAL BIOSENSO ... | Smith Judith Ann | Director | Grant | A | 0.31 | 200,000 | 62,000 | 300,000 | 100 K to 300 K (+200.00 %) |
Sep 15 2020 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.34 | 784,687 | 266,794 | 39,805,336 | 39 M to 39.8 M (+2.01 %) |
Sep 15 2020 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.33 | 80,178 | 26,459 | 39,020,649 | 38.9 M to 39 M (+0.21 %) |
Sep 15 2020 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.33 | 135,135 | 43,919 | 38,940,471 | 38.8 M to 38.9 M (+0.35 %) |
Sep 09 2020 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.30 | 500,000 | 150,000 | 500,000 | |
Sep 08 2020 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.33 | 322,315 | 104,752 | 38,805,336 | 38.5 M to 38.8 M (+0.84 %) |
Sep 08 2020 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.30 | 284,962 | 86,628 | 38,483,021 | 38.2 M to 38.5 M (+0.75 %) |
Sep 08 2020 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.32 | 100,000 | 32,100 | 38,198,059 | 38.1 M to 38.2 M (+0.26 %) |
Jul 30 2020 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.25 | 730,999 | 182,750 | 12,559,109 | 11.8 M to 12.6 M (+6.18 %) |
Jul 30 2020 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.25 | 1,461,998 | 365,500 | 38,098,059 | 36.6 M to 38.1 M (+3.99 %) |
Jul 09 2020 | UBI | UNIVERSAL BIOSENSO ... | CVC Ltd | 10% Owner | Sell | S | 0.22 | 23,820,765 | 5,240,568 | 0 | 23.8 M to 0 (-100.00 %) |
Dec 02 2019 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.20 | 119,519 | 23,904 | 36,636,061 | 36.5 M to 36.6 M (+0.33 %) |
Dec 02 2019 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.20 | 1,885,217 | 377,043 | 36,516,542 | 34.6 M to 36.5 M (+5.44 %) |
Dec 02 2019 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.19 | 214,783 | 41,024 | 34,631,325 | 34.4 M to 34.6 M (+0.62 %) |
Nov 25 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | See Remarks | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Nov 25 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | See Remarks | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Nov 25 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | See Remarks | Buy | M | 0.00 | 25,000 | 0 | 226,558 | 201.6 K to 226.6 K (+12.40 %) |
Nov 25 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | See Remarks | Buy | M | 0.00 | 25,000 | 0 | 226,558 | 201.6 K to 226.6 K (+12.40 %) |
Nov 18 2019 | UBI | UNIVERSAL BIOSENSO ... | VF Strategic Equities Fund | 10% Owner | Sell | S | 0.18 | 3,439,866 | 619,176 | 18,442,469 | 21.9 M to 18.4 M (-15.72 %) |
Nov 18 2019 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.19 | 36,500 | 6,935 | 34,416,542 | 34.4 M to 34.4 M (+0.11 %) |
Nov 18 2019 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.19 | 669,597 | 124,545 | 34,380,042 | 33.7 M to 34.4 M (+1.99 %) |
Sep 12 2019 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.19 | 80,000 | 15,200 | 33,710,445 | 33.6 M to 33.7 M (+0.24 %) |
Sep 12 2019 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.19 | 1,710,683 | 325,030 | 33,630,445 | 31.9 M to 33.6 M (+5.36 %) |
Sep 12 2019 | UBI | UNIVERSAL BIOSENSO ... | VF Strategic Equities Fund | 10% Owner | Buy | P | 0.19 | 80,000 | 15,200 | 21,882,335 | 21.8 M to 21.9 M (+0.37 %) |
Sep 12 2019 | UBI | UNIVERSAL BIOSENSO ... | VF Strategic Equities Fund | 10% Owner | Buy | P | 0.19 | 1,710,683 | 325,030 | 21,802,335 | 20.1 M to 21.8 M (+8.51 %) |
Jul 09 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 73,334 | 0 | 0 | |
Jul 09 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | M | 0.00 | 73,334 | 0 | 201,558 | 128.2 K to 201.6 K (+57.19 %) |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | M | 0.00 | 105,000 | 0 | 0 | |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | M | 0.00 | 40,000 | 0 | 0 | |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | M | 0.00 | 40,000 | 0 | 0 | |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Buy | M | 0.00 | 40,000 | 0 | 291,837 | 251.8 K to 291.8 K (+15.88 %) |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Buy | M | 0.00 | 40,000 | 0 | 251,837 | 211.8 K to 251.8 K (+18.88 %) |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Buy | M | 0.00 | 25,000 | 0 | 211,837 | 186.8 K to 211.8 K (+13.38 %) |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Buy | M | 0.00 | 105,000 | 0 | 186,837 | 81.8 K to 186.8 K (+128.30 %) |
Mar 06 2019 | UBI | UNIVERSAL BIOSENSO ... | CVC Ltd | 10% Owner | Buy | P | 0.21 | 176,151 | 36,992 | 23,820,765 | 23.6 M to 23.8 M (+0.74 %) |
Mar 05 2019 | UBI | UNIVERSAL BIOSENSO ... | CVC Ltd | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 23,644,614 | 23.5 M to 23.6 M (+0.42 %) |
Jan 14 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Jan 14 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 4,166 | 0 | 128,224 | 124.1 K to 128.2 K (+3.36 %) |
Jan 14 2019 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | M | 0.00 | 25,000 | 0 | 124,058 | 99.1 K to 124.1 K (+25.24 %) |
Jan 14 2019 | UBI | UNIVERSAL BIOSENSO ... | Legleiter Rick L | Chief Executive Off ... | Grant | A | 0.00 | 4,166 | 0 | 162,853 | 158.7 K to 162.9 K (+2.63 %) |
Jan 14 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Jan 14 2019 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Buy | M | 0.00 | 25,000 | 0 | 81,837 | 56.8 K to 81.8 K (+43.99 %) |
Dec 06 2018 | UBI | UNIVERSAL BIOSENSO ... | CVC Ltd | 10% Owner | Buy | P | 0.21 | 1,500,000 | 315,000 | 23,544,614 | 22 M to 23.5 M (+6.80 %) |
Nov 05 2018 | UBI | UNIVERSAL BIOSENSO ... | CVC Ltd | 10% Owner | Buy | P | 0.23 | 100,000 | 23,000 | 22,044,614 | 21.9 M to 22 M (+0.46 %) |
May 11 2018 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.24 | 66,584 | 15,980 | 11,823,530 | 11.8 M to 11.8 M (+0.57 %) |
May 11 2018 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.24 | 66,584 | 15,980 | 31,915,182 | 31.8 M to 31.9 M (+0.21 %) |
May 08 2018 | UBI | UNIVERSAL BIOSENSO ... | Legleiter Rick L | Chief Executive Off ... | Buy | P | 0.26 | 158,687 | 41,021 | 158,687 | 0 to 158.7 K |
May 07 2018 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.23 | 198,640 | 46,084 | 11,756,946 | 11.6 M to 11.8 M (+1.72 %) |
May 07 2018 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.23 | 124,305 | 28,342 | 11,558,306 | 11.4 M to 11.6 M (+1.09 %) |
May 07 2018 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.23 | 198,640 | 46,084 | 31,848,598 | 31.6 M to 31.8 M (+0.63 %) |
May 07 2018 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.23 | 124,305 | 28,342 | 31,649,958 | 31.5 M to 31.6 M (+0.39 %) |
Mar 19 2018 | UBI | UNIVERSAL BIOSENSO ... | Hoey David L | Director | Buy | P | 0.21 | 100,000 | 20,510 | 566,414 | 466.4 K to 566.4 K (+21.44 %) |
Feb 05 2018 | UBI | UNIVERSAL BIOSENSO ... | Hoey David L | Director | Buy | P | 0.23 | 116,414 | 26,775 | 466,414 | 350 K to 466.4 K (+33.26 %) |
Feb 05 2018 | UBI | UNIVERSAL BIOSENSO ... | Hoey David L | Director | Buy | P | 0.23 | 116,414 | 26,775 | 466,414 | 350 K to 466.4 K (+33.26 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.30 | 3,001,271 | 900,381 | 31,525,653 | 28.5 M to 31.5 M (+10.52 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.29 | 201,498 | 59,240 | 28,524,382 | 28.3 M to 28.5 M (+0.71 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.29 | 224,982 | 65,020 | 28,322,884 | 28.1 M to 28.3 M (+0.80 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.27 | 134,451 | 36,167 | 28,097,902 | 28 M to 28.1 M (+0.48 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF Strategic Equities Fund | 10% Owner | Buy | P | 0.30 | 2,250,953 | 675,286 | 20,091,652 | 17.8 M to 20.1 M (+12.62 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF Strategic Equities Fund | 10% Owner | Buy | P | 0.29 | 151,124 | 44,430 | 17,840,699 | 17.7 M to 17.8 M (+0.85 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF Strategic Equities Fund | 10% Owner | Buy | P | 0.29 | 168,737 | 48,765 | 17,689,575 | 17.5 M to 17.7 M (+0.96 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF Strategic Equities Fund | 10% Owner | Buy | P | 0.27 | 100,838 | 27,125 | 17,520,838 | 17.4 M to 17.5 M (+0.58 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.30 | 750,318 | 225,095 | 11,434,001 | 10.7 M to 11.4 M (+7.02 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.29 | 50,374 | 14,810 | 10,683,683 | 10.6 M to 10.7 M (+0.47 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.29 | 56,245 | 16,255 | 10,633,309 | 10.6 M to 10.6 M (+0.53 %) |
Dec 29 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.27 | 33,613 | 9,042 | 10,577,064 | 10.5 M to 10.6 M (+0.32 %) |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Buy | M | 0.00 | 25,000 | 0 | 2,871,615 | 2.8 M to 2.9 M (+0.88 %) |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | VP Technology Devel ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | VP Technology Devel ... | Buy | M | 0.00 | 25,000 | 0 | 2,275,594 | 2.3 M to 2.3 M (+1.11 %) |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Buy | M | 0.00 | 16,667 | 0 | 99,058 | 82.4 K to 99.1 K (+20.23 %) |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Legleiter Rick L | Chief Executive Off ... | Option Exercise | A | 0.80 | 3,300,000 | 2,640,000 | 3,300,000 | |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Legleiter Rick L | Chief Executive Off ... | Option Exercise | A | 0.60 | 2,700,000 | 1,620,000 | 2,700,000 | |
Oct 26 2017 | UBI | UNIVERSAL BIOSENSO ... | Legleiter Rick L | Chief Executive Off ... | Option Exercise | A | 0.50 | 1,600,000 | 800,000 | 1,600,000 | |
Aug 17 2017 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Aug 17 2017 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Aug 17 2017 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Buy | M | 0.00 | 41,667 | 0 | 56,837 | 15.2 K to 56.8 K (+274.67 %) |
Mar 27 2017 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Grant | A | 0.00 | 3,030 | 0 | 15,170 | 12.1 K to 15.2 K (+24.96 %) |
Mar 27 2017 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 0.00 | 3,030 | 0 | 2,846,615 | 2.8 M to 2.8 M (+0.11 %) |
Mar 27 2017 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 3,030 | 0 | 82,391 | 79.4 K to 82.4 K (+3.82 %) |
Mar 27 2017 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 0.00 | 3,030 | 0 | 2,250,594 | 2.2 M to 2.3 M (+0.13 %) |
Mar 01 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.38 | 32,988 | 12,535 | 27,963,451 | 27.9 M to 28 M (+0.12 %) |
Mar 01 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.39 | 247,001 | 95,095 | 27,930,463 | 27.7 M to 27.9 M (+0.89 %) |
Mar 01 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.38 | 402,924 | 153,917 | 27,683,462 | 27.3 M to 27.7 M (+1.48 %) |
Mar 01 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.38 | 32,988 | 12,535 | 10,543,451 | 10.5 M to 10.5 M (+0.31 %) |
Mar 01 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.39 | 247,001 | 95,095 | 10,510,463 | 10.3 M to 10.5 M (+2.41 %) |
Mar 01 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.38 | 402,924 | 153,917 | 10,263,462 | 9.9 M to 10.3 M (+4.09 %) |
Feb 17 2017 | UBI | UNIVERSAL BIOSENSO ... | Smith Judith Ann | Director | Grant | A | 0.37 | 65,000 | 23,725 | 100,000 | 35 K to 100 K (+185.71 %) |
Feb 17 2017 | UBI | UNIVERSAL BIOSENSO ... | Smith Judith Ann | Director | Grant | A | 0.34 | 35,000 | 11,725 | 35,000 | 0 to 35 K |
Feb 16 2017 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.34 | 7,782 | 2,646 | 27,280,538 | 27.3 M to 27.3 M (+0.03 %) |
Feb 16 2017 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.34 | 7,782 | 2,646 | 9,860,538 | 9.9 M to 9.9 M (+0.08 %) |
Jan 03 2017 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 3,030 | 0 | 82,391 | 79.4 K to 82.4 K (+3.82 %) |
Jan 03 2017 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Grant | A | 0.00 | 3,030 | 0 | 15,170 | 12.1 K to 15.2 K (+24.96 %) |
Jan 03 2017 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 0.00 | 3,030 | 0 | 2,250,594 | 2.2 M to 2.3 M (+0.13 %) |
Jan 03 2017 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 0.00 | 3,030 | 0 | 2,846,615 | 2.8 M to 2.8 M (+0.11 %) |
Dec 08 2016 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.33 | 16,078 | 5,381 | 27,272,756 | 27.3 M to 27.3 M (+0.06 %) |
Dec 08 2016 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.33 | 16,078 | 5,381 | 9,852,756 | 9.8 M to 9.9 M (+0.16 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.33 | 112,009 | 36,761 | 9,836,678 | 9.7 M to 9.8 M (+1.15 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.32 | 154,736 | 49,516 | 9,724,669 | 9.6 M to 9.7 M (+1.62 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.32 | 165,000 | 52,800 | 9,569,933 | 9.4 M to 9.6 M (+1.75 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | VF High Conviction Fund | 10% Owner | Buy | P | 0.32 | 1,807,004 | 577,518 | 9,404,933 | 7.6 M to 9.4 M (+23.78 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | VF Australian Equities Fund | 10% Owner | Sell | S | 0.32 | 154,736 | 49,516 | 0 | 154.7 K to 0 (-100.00 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.33 | 112,009 | 36,761 | 27,256,678 | 27.1 M to 27.3 M (+0.41 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.32 | 165,000 | 52,800 | 27,144,669 | 27 M to 27.1 M (+0.61 %) |
Dec 05 2016 | UBI | UNIVERSAL BIOSENSO ... | Coleman Craig E. | Director | Buy | P | 0.32 | 1,807,004 | 577,518 | 26,979,669 | 25.2 M to 27 M (+7.18 %) |
Sep 30 2016 | UBI | UNIVERSAL BIOSENSO ... | Hoey David L | Director | Buy | P | 0.29 | 150,000 | 43,500 | 350,000 | 200 K to 350 K (+75.00 %) |
Jun 14 2016 | UBI | UNIVERSAL BIOSENSO ... | Hoey David L | Director | Buy | P | 0.29 | 200,000 | 58,000 | 200,000 | 0 to 200 K |
Jun 14 2016 | UBI | UNIVERSAL BIOSENSO ... | Hoey David L | Director | Buy | P | 0.29 | 200,000 | 58,000 | 200,000 | 0 to 200 K |
Feb 26 2016 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Grant | A | 0.00 | 2,500 | 0 | 12,140 | 9.6 K to 12.1 K (+25.93 %) |
Feb 26 2016 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 2,500 | 0 | 79,361 | 76.9 K to 79.4 K (+3.25 %) |
Feb 25 2016 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 0.00 | 2,500 | 0 | 2,843,585 | 2.8 M to 2.8 M (+0.09 %) |
Feb 19 2016 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 0.00 | 2,500 | 0 | 2,247,564 | 2.2 M to 2.2 M (+0.11 %) |
Feb 19 2016 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Sell | S | 0.45 | 100,000 | 45,000 | 2,245,064 | 2.3 M to 2.2 M (-4.26 %) |
Jan 14 2016 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | M | 0.26 | 36,248 | 9,424 | 0 | |
Jan 14 2016 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Buy | M | 0.26 | 36,248 | 9,424 | 2,841,085 | 2.8 M to 2.8 M (+1.29 %) |
Jan 14 2016 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Sell | D | 0.46 | 30,000 | 13,800 | 2,804,837 | 2.8 M to 2.8 M (-1.06 %) |
Jul 13 2015 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jul 13 2015 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Grant | A | 0.00 | 4,347 | 0 | 7,304 | 3 K to 7.3 K (+147.01 %) |
Mar 02 2015 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Buy | P | 99,812.60 | 269,088 | 26,858,364,836 | 606,516 | 337.4 K to 606.5 K (+79.75 %) |
Feb 24 2015 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Grant | A | 101,820.00 | 337,428 | 34,356,858,223 | 337,428 | 0 to 337.4 K |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 0.00 | 4,347 | 0 | 2,834,837 | 2.8 M to 2.8 M (+0.15 %) |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Grant | A | 0.00 | 4,347 | 0 | 2,345,064 | 2.3 M to 2.3 M (+0.19 %) |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Oates Adrian | See Remarks | Grant | A | 0.00 | 4,347 | 0 | 9,640 | 5.3 K to 9.6 K (+82.13 %) |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Feb 03 2015 | UBI | UNIVERSAL BIOSENSO ... | Balak Salesh | Chief Financial Off ... | Grant | A | 0.00 | 4,347 | 0 | 76,861 | 72.5 K to 76.9 K (+5.99 %) |
May 16 2014 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 7,670.00 | 50,000 | 383,500,000 | 2,886,340 | 2.8 M to 2.9 M (+1.76 %) |
May 16 2014 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 8,940.00 | 50,000 | 447,000,000 | 2,836,340 | 2.8 M to 2.8 M (+1.79 %) |
Jun 13 2014 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jun 13 2014 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Grant | A | 0.00 | 2,040 | 0 | 2,957 | 917 to 3 K (+222.46 %) |
May 14 2014 | UBI | UNIVERSAL BIOSENSO ... | Hanley Denis | Director | Buy | P | 8,127.90 | 50,000 | 406,395,000 | 1,918,002 | 1.9 M to 1.9 M (+2.68 %) |
May 13 2014 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 11,500.00 | 50,000 | 575,000,000 | 2,786,340 | 2.7 M to 2.8 M (+1.83 %) |
May 13 2014 | UBI | UNIVERSAL BIOSENSO ... | DENVER ANDREW | Director | Buy | P | 6,610.50 | 30,000 | 198,315,000 | 90,797 | 60.8 K to 90.8 K (+49.34 %) |
May 08 2014 | UBI | UNIVERSAL BIOSENSO ... | Smith Christopher M | Director | Buy | P | 11,250.00 | 30,000 | 337,498,500 | 30,000 | 0 to 30 K |
Apr 16 2014 | UBI | UNIVERSAL BIOSENSO ... | Wright Paul | Chief Executive Off ... | Grant | A | 56,567.10 | 142,105 | 8,038,464,903 | 186,771 | 44.7 K to 186.8 K (+318.15 %) |
Jan 08 2014 | UBI | UNIVERSAL BIOSENSO ... | Davis Frederick Harry | VP Business Develop ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 08 2014 | UBI | UNIVERSAL BIOSENSO ... | Davis Frederick Harry | VP Business Develop ... | Grant | A | 0.00 | 2,040 | 0 | 2,957 | 917 to 3 K (+222.46 %) |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | M | 0.22 | 384,224 | 84,529 | 0 | |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Buy | M | 0.22 | 384,224 | 84,529 | 2,830,490 | 2.4 M to 2.8 M (+15.71 %) |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Hodges Alastair | Chief Scientist | Grant | A | 0.00 | 2,040 | 0 | 2,446,266 | 2.4 M to 2.4 M (+0.08 %) |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | M | 0.22 | 288,168 | 63,397 | 0 | |
Jan 06 2014 | UBI | UNIVERSAL BIOSENSO ... | Chambers Garry | Vice President, Ope ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 |